Faculty director of the O’Neill Institute for National and Global Health Law at Georgetown Law. He is professor of medicine at Georgetown University School of Medicine and professor of public health at the Johns Hopkins University. Gostin is a co-director of the World Health Organization Collaborating Center on National and Global Health Law and has served on numerous WHO expert advisory committees related to public health and global health security. Gostin serves on the Independent Panel on the Global Response to Ebola (Harvard University/London School of Hygiene and Tropical Medicine) and served on the National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future.
Director, Preventative Cardiology and Women's HearOhio State University Wexner Medical Center
Women's Heart Health, Women's Heart Disease, preventative cardiology, Cardiovascular Disease Prevention, Cardiovascular Disease, cardiovascular disease and women, Cardiac Rehabilitation, Cardiac Imaging
Laxmi Mehta, M.D., FACC, FAHA is the Director of the Women’s Cardiovascular Health Program and an Associate Professor of Medicine at The Ohio State University Wexner Medical Center. Dr. Mehta is also the Associate Program Director for Education for Ohio State’s Center for Women’s Health. She is the President of the Ohio Chapter of the American College of Cardiology and has previously served two terms as Secretary/Treasurer for the Ohio-ACC Chapter. Additionally, she is the Immediate Past President of the metro Columbus Board of Directors for the American Heart Association and now currently serves on the Great Rivers Affiliate Board for the American Heart Association. She sits on several national committees for both the American College of Cardiology and the American Heart Association. Dr. Mehta was chosen by Business First Magazine as one of Columbus' Top 40 under 40 in 2010 and honored as one of 12 women for the 2012 Women for Economic Leadership (WELD) Women You Should Know Calendar Honoree. She specializes in women’s cardiovascular health, prevention and cardiac imaging. Dr. Mehta is an avid promoter and educator on women’s cardiovascular health and has published a number of peer-reviewed articles and book chapters. She is a Fellow of the American College of Cardiology and the American Heart Association. She received her M.D. degree from Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown, Ohio in 1998. She completed her Internal Medicine residency training and Clinical Cardiology fellowship training at William Beaumont Hospital in Royal Oak, Michigan in 2001 and 2005.
Doctor and cognitive neuroscientistThe Neuro - Montreal Neurological Institute and Hospital
Decision Making, AIDS, Cognition, Neuroscience, Cognition Dysfunction
Dr. Lesley Fellows is a neurologist specializing in disorders of cognition. She has a particular interest in the functions of the brain's frontal lobes. Her research program focuses on the brain basis of decision making in humans, using the tools of cognitive neuroscience. She studies how focal brain damage or neurochemical dysfunction affects all aspects of decision making, how options are generated and organized, how they are valued and compared, and how choices are made. She is also interested in more general questions about the roles of the frontal lobes in the regulation of emotion, the expression of personality traits, and the representation of past and future information. This work has relevance for understanding impaired executive function following frontal lobe injury from aneurysm rupture, stroke, or tumor growth, as well as in degenerative conditions such as Parkinson’s Disease and some forms of dementia. It also provides insights into how the component processes that underlie decision making are carried out in the intact brain.
Distinguished Service Professor of EnglishBinghamton University, State University of New York
Children's Folklore , Folklore, Digital Folklore , Children's Study, Legends
Assistant Professor of Health and Wellness StudiesBinghamton University, State University of New York
Nutrigenomics, Neurodegeneration, Nutrition, Mental Distress, Microbiota, Food
Before entering academia, Farman held several positions in the advertising industry. At Smiley360, she executed social media campaigns for popular consumer brands such as Country Crock, Schick, Staples and Florida's Natural Orange Juice. As an account supervisor on the IBM worldwide team at the advertising agency Ogilvy & Mather, she led advertising and direct marketing campaigns, managed clients and teams across six continents, and contributed to the development of the "Smarter Planet" campaign. She also worked at Market Maker Interactive, a web design agency, as a web copy writer and client manager for both consumer and business-to-business brands. Farman has taught courses on Media Planning and Research & Statistics for Strategic Communication.
Lori Peek is director of the Natural Hazards Center and professor in the Department of Sociology at the University of Colorado Boulder. She studies vulnerable populations in disaster and has conducted field investigations in the aftermath of the 9/11 terrorist attacks, Hurricane Katrina, the BP Oil Spill, the Christchurch earthquakes, the Joplin tornado, Superstorm Sandy, and Hurricane Matthew. She is currently co-leading a National Science Foundation-funded workshop series on methods of interdisciplinary disaster research and she is a member of the social science team for the National Institute of Standards and Technology Center of Excellence for Risk Based Community Resilience Planning. She is also working on several ongoing projects related to children’s health and well-being before, during, and after disaster.
Luis Rafael Herrera-Estrella is the President's Distinguished Professor of Plant Genomics and the Director for the Center for Functional Genomics of Abiotic Stress in the Department of Plant and Soil Science at Texas Tech University's College of Agricultural Sciences & Natural Resources. Dr. Herrera-Estrella came to Texas Tech in 2018 thanks to a grant from the State of Texas Governor's University Research Initiative (GURI). He leads a team in the Center that examines how plants adapt to thrive in the presence of environmental stresses such as extreme heat and cold, drought and in the presence of brackish water sources. Herrera-Estrella is known and respected worldwide for his work in cotton genomics, having earned the distinction in 2015 as one of the 100 most influential people in biotechnology by Scientific American. He previously served as the director and full professor of the National Laboratory of Genomics for Biodiversity (LANGEBIO) in Guanajuato, Mexico, where remains a professor emeritus. His research focuses on the molecular mechanisms that allow plants to cope with a continuously changing environment. In particular, he has studied the two fundamental processes of molecular responses to light as a source of energy and a developmental signal, and nutrient availability. Herrera-Estrella was able to eventually identify DNA regulatory elements that allow plants to activate genes in response to light stimuli and the protein sequence present in many corresponding gene products that ultimately allow participation in the photosynthesis process. A holder of 15 patents, Herrera-Estrella has published more than 180 research papers and 47 book chapters and other reviews while having delivered more than 200 presentations on his work. He served as a senior international research scholar at the Howard Hughes Biomedical Institute from 2012 to 2017 and earned the Dr. Luis Federico Leloir Award in 2012 from the Argentinian Ministry of Science, Technology and Innovation. Herrera-Estrella earned his doctoral and postdoctoral degrees in genetics from the State University of Ghent, Belgium. He received his master’s degree in genetics and molecular biology from the Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, and his bachelor’s degree from Escuela Nacional de Ciencias Biológicas Instituto Politécnico Nacional.
Dr. Daadi is an expert in regulated translational research and has developed therapeutic neural stem cell lines (NSC) for clinical use in Parkinson’s disease, stroke, and to target brain tumors in both industrial and academic settings. He discovered a novel technique of engineering these stem cell lines from pluripotent human embryonic stem cells and continues to develop this therapeutic cell line for clinical use. Dr. Daadi came to Texas Biomed in 2014 and is the team leader for the SNPRC Regenerative Medicine and Aging research unit. Results from his studies are the foundation of translational research and help to repair diseased or injured brain through transplantation of highly purified NSCs and stimulation of internal repair mechanisms.
Marie Griffith, the John C. Danforth Distinguished Professor in the Humanities at Washington University in St. Louis, is currently the director of the John C. Danforth Center on Religion and Politics and the editor of the Center’s journal, Religion & Politics. Griffith is a frequent media commentator and public speaker on current issues pertaining to religion and politics, including the changing profile of American evangelicals and ongoing conflicts over gender, sexuality and marriage.
Dr. Gauduin has more than 25 years of experience in HIV/AIDS research and medical microbiology. She has been working extensively on HIV and the development of novel vaccine strategies using the non-human primate model for AIDS. In her work, she uses epithelial stem cells and weakened recombinant papillomavirus as vaccine- vectors to protect against multiple low-dose mucosal challenges. Dr. Gauduin is also developing a neonatal model for tuberculosis to study HIV/TB co-infection in pediatric AIDS. Her specific research interests are: Early events of simian immunodeficiency virus (SIV) transmission in a macaque model Host immune responses to infectious diseases Early virus-specific T cell responses in neonates Tuberculosis/SIV coinfection in pediatric AIDS
prosocial behavior, Intrinsic Reward, Extrinsic Values, Moral Behavior, moral decisions, Global Health, Experimental Economics, development economics, Labor, Human Resources, Johns Hopkins Carey Business School, Johns Hopkins Medicine
Mario Macis, PhD (Economics, University of Chicago) is an associate professor in the research track with expertise in the areas of prosocial behavior, morally controversial transactions, global health, experimental economics, development economics, and labor economics. He is also Affiliate Faculty at the JHU Berman Institute of Bioethics, Associate Faculty at the Armstrong Institute for Patient Safety and Quality at JHU Medicine, Faculty Research Fellow in the National Bureau of Economic Research (NBER), and Research Fellow at the Institute for the Study of Labor (IZA). Dr. Macis has been a consultant for the World Bank, the International Labor Organization, the National Marrow Donor Program, and the United Nations Development Programme.
Marjorie A. Speers, Ph.D., is a global leader in human research protections. Most recently, she was the inaugural president and CEO of the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), retiring in 2013. Dr. Speers views the opportunity to lead this one-of-a-kind foundation—and continue to contribute to research protections and public well-being worldwide—as the natural progression in an exemplary career of public service. Before establishing AAHRPP in 2001, she served as acting executive director of the National Bioethics Advisory Commission. At the Centers for Disease Control and Prevention, she oversaw research protections for all domestic and international research. Dr. Speers is a graduate of Dickinson College, where she serves on the Board of Trustees and established a scholarship that has benefited numerous international students. She also holds doctoral degrees in psychology and epidemiology from Yale University.
Dr. Katlic serves as chief of the Department of Surgery and surgeon-in-chief at Sinai Hospital, is the director of the Sinai Center for Geriatric Surgery and is the founder of The Aging Surgeon Program. While a resident at the Massachusetts General Hospital, he cared for several 100-year old surgical patients and reviewed the records of other elderly patients publishing his results in 1985 in the Journal of the American Medical Association. He is also an author of five textbooks on geriatric surgery. The Aging Surgeon Program is a comprehensive evaluation of the physical and cognitive functions of older surgeons.
Mark is the Queen's Lead of the £5M Medical Research Council-Cancer Research UK funded Stratified Medicine in Colorectal Cancer Consortium (S:CORT), a UK-wide consortium investigating novel precision medicine approaches in colorectal cancer(CRC). His international reputation in CRC was instrumental in his leading a Critical Gaps in Colorectal Cancer Research Initiative, recently published in the high impact factor journal Gut; this landmark publication has attracted significant global attention (his podcast had the most “hits” of any article in the journal) Mark is Queen's Lead of the Health Data Research UK Substantive Site, one of only 6 in the UK, which aims to drive innovative precision medicine and public health approaches through the use of Big Data. He is also national lead for Cancer Strategy for HDR-UK. Mark was co-chair of the Cancer Task Team of the Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH), an international cooperative dedicated to effective and responsible sharing of genomic and clinical data. He has authored a number of key papers including a blueprint for cancer date sharing (published in Nature Medicine) and a road map/call to action for a Global Cancer Knowledge Network in the New England Journal of Medicine Mark has published over 180 papers in international peer review journals, including key papers in the highest impact journals (New Engl J Medicine, Lancet, Nature Medicine, Lancet Oncology, Cancer Discovery, Nature Comms, Gut etc). He is co-lead of an ambitious proposal to develop a Global Innovation Institute in Belfast which will include the One Health Innovation Centre (OHIC), the world’s first Health and Agri-Food Informatics Innovation Centre. Mark’s work has been recognised by a number of national/international awards including the Vander Molen Prize for Leukaemia Research, the Ely Lilly Prize, the St Lukes Medal for Cancer Research and the Graves Medal for Medical Research. He is frequently invited as a guest speaker to international conferences and sits on a number of high level boards/committees at European level including the European Alliance for Personalised Medicine, the Scientific Board of the European Cancer Patient Coalition and the European Cancer Organisation (ECCO) Oncopolicy Forum Mark has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was the architect of the European Cancer Patient's Bill of Rights (BoR), a catalyst for change and empowerment tool for cancer patients which he launched in the European Parliament on World Cancer Day 2014. The BoR has been adopted across Europe and led to the 70:35 Vision, 70% survival for all cancer patients in Europe by 2035 which was recently adopted by ECCO, the largest interdisciplinary cancer organisation in Europe. Mark’s advocacy work was instrumental in the recent decision to include boys in national UK HPV vaccination programmes. He is also committed to the provision of optimal pathology and laboratory medicine for citizens in resource-limited settings and was senior author of a recent paper in The Lancet as part of The Lancet Series on Pathology and Laboratory Medicine in Low- and Middle- Income Countries.
Dr. Rupp is a Professor in the Department of Internal Medicine, Section of Infectious Diseases at the University of Nebraska Medical Center. He is the Medical Director of The Nebraska Medical Center Department of Healthcare Epidemiology and co-Director of the Antimicrobial Stewardship Program. Dr. Rupp received his medical degree from Baylor College of Medicine, Houston, Texas and holds a B.S. degree in Chemical Engineering from the University of Texas, Austin, Texas. He underwent internship and residency training in Internal Medicine at Virginia Commonwealth University and completed a Fellowship in Infectious Diseases at VCU. He is a Diplomate, American Board of Internal Medicine, and in the subspecialty area of Infectious Diseases. He is a Fellow of the Society for Hospital Epidemiology of America (SHEA), American College of Physicians (ACP), and the Infectious Diseases Society of America (IDSA). He is a Past-President of SHEA and is a past-president of ASM Division L (Infection Control/Hospital Epidemiology). Dr Rupp has served as a consultant for the US Food and Drug Administration as well as the Centers for Disease Control and Prevention. Dr. Rupp has published over 300 articles, chapters and abstracts and is the editor of a textbook entitled “Biofilms, Infections, and Antimicrobial Therapy.” He frequently presents papers at national and international meetings, serves as a guest lecturer, and is an active teacher and researcher. Dr. Rupp’s research interests are in the areas of staphylococcal disease, healthcare-associated infections, and antimicrobial resistance.